OBJECTIVE
The Office of National Drug Control Policy circular: National Drug Control Program Agency Compliance Reviews requires agencies expending funds on National Drug Control Program activities to submit an accounting of such funds made during the previous fiscal year (21 U.S.C. § 1704). The policy also requires that an agency submit with its annual accounting an authentication provided by the agency's OIG that expresses a conclusion on the reliability of the agency's assertions. The circular states that if in an agency's prior year drug-related obligations were less than $50 million, the agency would not be subject to these authentication requirements. We will review how HHS agencies complied with this circular and will submit the authentication with respect to the HHS agencies' annual accounting, beginning with FY 2020, once every three years.
There are 3 projects in this series.
Project titles will remain unpublished until projects are complete and reports are posted.
ACTIVE PROJECTS IN THIS SERIES (3)
TIMELINE
-
December 19, 2025Series Number SRS-A-26-009 Assigned
-
December 19, 2025Projects Announced
Project OAS-26-03-023
-
Project OAS-26-03-024
-
Project OAS-26-03-025
-
Today3 Projects In-Progress
-
Est FY2027Estimated Fiscal Year for Series Completion